These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6143907)

  • 1. Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis?
    Cerletti C; Chiabrando C; Fanelli R; de Gaetano G
    Lancet; 1984 Apr; 1(8383):967-8. PubMed ID: 6143907
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
    Maguire ED; Wallis RB
    Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
    Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
    Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
    Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
    Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
    Henriksson P; Rasmanis G; Edhag O; Vesterqvist O; Gréen K
    Prostaglandins; 1990 Jan; 39(1):99-107. PubMed ID: 2106716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
    Ritter JM
    Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G; Deckmyn H; Vermylen J
    Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion.
    Menys VC; Davies JA
    Thromb Haemost; 1983 Apr; 49(2):96-101. PubMed ID: 6346575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
    Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of thromboxane synthetase by dazoxiben increases prostacyclin production by leukocytes in angina patients and healthy volunteers.
    Parry MJ; Randall MJ; Tyler HM; Myhre E; Dale J; Thaulow E
    Lancet; 1982 Jul; 2(8290):164. PubMed ID: 6123880
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
    Pedersen AK; Watson ML; FitzGerald GA
    Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J; Defreyn G; Carreras LO; Machin SJ; Van Schaeren J; Verstraete M
    Lancet; 1981 May; 1(8229):1073-5. PubMed ID: 6112447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane synthetase inhibition: potential therapy in migraine.
    Joseph R; Steiner JT; Poole CJ; Littlewood J; Rose FC
    Headache; 1985 Jun; 25(4):204-7. PubMed ID: 3839492
    [No Abstract]   [Full Text] [Related]  

  • 20. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
    Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
    Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.